{"id":11079,"date":"2024-07-12T16:22:00","date_gmt":"2024-07-12T14:22:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=11079"},"modified":"2025-08-08T16:24:32","modified_gmt":"2025-08-08T14:24:32","slug":"the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/","title":{"rendered":"The role of fecal biomarkers in individuals with inflammatory bowel disease"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Edwards+TS&amp;cauthor_id=38995110\">Teagan S Edwards<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38995110\/#full-view-affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Day+AS&amp;cauthor_id=38995110\">Andrew S Day<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38995110\/#full-view-affiliation-1\">1<\/a><\/sup><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>Expert Rev Mol Diagn..\u00a02024 Jun;24(6):497-508.\u00a0doi: 10.1080\/14737159.2024.2375224.\u00a0Epub 2024 Jul 12.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Introduction:&nbsp;<\/strong>Inflammatory bowel disease (IBD), encompassing Crohn&#8217;s disease (CD) and Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have an increasingly important role in the diagnosis of IBD and in the prediction of future disease course in individuals with IBD. Strategies for the management of IBD increasingly rely upon close monitoring of gastrointestinal inflammation.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Areas covered:&nbsp;<\/strong>This review provides an update on the current understanding of established and novel stool-based biomarkers in the diagnosis and management of IBD. It also highlights key gaps, identifies limitations, and advantages of current markers, and examines aspects that require further study and analysis.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Expert opinion:\u00a0<\/strong>Current noninvasive inflammatory markers play an important role in the diagnosis and management of IBD; however, limitations exist. Future work is required to further characterize and validate current and novel markers of inflammation. In addition, it is essential to better understand the roles and characteristics of noninvasive markers to enable the appropriate selection to accurately determine the condition of the intestinal mucosa.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<ul class=\"wp-block-list\" id=\"list_0001\">\n<li>Noninvasive inflammatory markers play an important role in diagnosis and management of IBD.<\/li>\n\n\n\n<li>Fecal inflammatory markers can reflect gut inflammation in IBD; however, they are not specific and various limitations must be considered.<\/li>\n\n\n\n<li>Although FCal is the most well-established and routinely used marker in IBD, it may have reduced sensitivity and specificity in some settings.<\/li>\n\n\n\n<li>Several emerging biomarkers including MPO have been assessed and show promise.<\/li>\n\n\n\n<li>Identification of effective and accurate noninvasive markers of inflammation may limit the need for repeat invasive endoscopic examinations in the future.<\/li>\n<\/ul>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Teagan S Edwards\u00a01,\u00a0Andrew S Day\u00a01 Expert Rev Mol Diagn..\u00a02024 Jun;24(6):497-508.\u00a0doi: 10.1080\/14737159.2024.2375224.\u00a0Epub 2024 Jul 12. Introduction:&nbsp;Inflammatory bowel disease (IBD), encompassing Crohn&#8217;s disease (CD) and Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have an increasingly important role in the diagnosis of IBD and in the prediction of future disease course in individuals with [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[483,902,654,426,106,581,445,904],"class_list":["post-11079","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-biomarkers","scientific_tags-fecal-2","scientific_tags-fecal-calprotectin","scientific_tags-ibd","scientific_tags-inflammation","scientific_tags-mpo","scientific_tags-neutrophil","scientific_tags-noninvasive"],"acf":{"sc_authors":"<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38995110\/\">https:\/\/pubmed.ncbi.nlm.nih.gov\/38995110\/<\/a>\r\n\r\n<a href=\"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737159.2024.2375224\">https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737159.2024.2375224<\/a>"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Teagan S Edwards\u00a01,\u00a0Andrew S Day\u00a01 Expert Rev Mol Diagn..\u00a02024 Jun;24(6):497-508.\u00a0doi: 10.1080\/14737159.2024.2375224.\u00a0Epub 2024 Jul 12. Introduction:&nbsp;Inflammatory bowel disease (IBD), encompassing Crohn&#8217;s disease (CD) and Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have an increasingly important role in the diagnosis of IBD and in the prediction of future disease course in individuals with [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-08T14:24:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/\",\"name\":\"The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2024-07-12T14:22:00+00:00\",\"dateModified\":\"2025-08-08T14:24:32+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/","og_locale":"es_ES","og_type":"article","og_title":"The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte","og_description":"Teagan S Edwards\u00a01,\u00a0Andrew S Day\u00a01 Expert Rev Mol Diagn..\u00a02024 Jun;24(6):497-508.\u00a0doi: 10.1080\/14737159.2024.2375224.\u00a0Epub 2024 Jul 12. Introduction:&nbsp;Inflammatory bowel disease (IBD), encompassing Crohn&#8217;s disease (CD) and Ulcerative Colitis (UC), is a relapsing and remitting condition. Noninvasive biomarkers have an increasingly important role in the diagnosis of IBD and in the prediction of future disease course in individuals with [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/","og_site_name":"Adacyte","article_modified_time":"2025-08-08T14:24:32+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/","name":"The role of fecal biomarkers in individuals with inflammatory bowel disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2024-07-12T14:22:00+00:00","dateModified":"2025-08-08T14:24:32+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/the-role-of-fecal-biomarkers-in-individuals-with-inflammatory-bowel-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/11079","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=11079"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=11079"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}